Thailand Pharmaceuticals and Healthcare Report Q2 2016
BMI View: Multinational drugmakers will continue to face a difficult business environment in Thailand. Designated as a 'Priority Watch List Country' for PhRMA's Special 301 submission for 2016, key issues highlighted in 2015 remain unaddressed. This includes low levels of intellectual property protection as well as a challenging procurement process that favours the Government Procurement Organization. Cost containment pressures will also become more acute as authorities seek to curb rising healthcare spending.
Headline Expenditure Projections
Pharmaceuticals: THB152bnbn (USD4.4bn) in 2015 to THB160bn (USD4.5bn) in 2016; +5.3% in local currency terms and +1.9% in US dollar terms.
Healthcare: THB614bn (USD17.9bn) in 2015 to THB655bn (USD18.5bn) in 2016: +6.7% in local currency and +-3.3% in US dollar terms.
- BMI Industry View
- Table: Headline Pharmaceuticals & Healthcare Forecasts (Thailand 2014-2020)
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Table: Pharmaceutical Sales, Historical Data And Forecasts (Thailand 2012-2020)
- Healthcare Market Forecast
- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020)
- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020)
- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020)
- Prescription Drug Market Forecast
- Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
- Generic Drug Market Forecast
- Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
- OTC Medicine Market Forecast
- Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Trade Data And Forecasts (Thailand 2014-2020)
- Table: Pharmaceutical Trade Data And Forecasts local currency (Thailand 2014-2020)
- Industry Risk/Reward Index
- Asia Pacific Risk/Reward Index
- Thailand Risk/Reward Index
- Rewards
- Risks
- Regulatory Review
- Intellectual Property Issues
- Pricing Regime
- Table: Price Build-Up Of Medicines In Thailand
- Reimbursement Regime
- Market Overview
- Healthcare Sector
- Table: Major Health Insurance Programmes In Thailand
- Table: Healthcare Resources (Thailand 2010-2015)
- Table: Healthcare Personnel (Thailand 2010-2015)
- Table: Healthcare Activity (Thailand 2010-2015)
- Research & Development
- Clinical Trials
- Epidemiology
- Table: Estimated Number Of New Cases Of Cancer In Thailand
- Competitive Landscape
- Research-Based Industry
- Table: PReMA Members
- Table: Multinational Market Activity
- Generic Drugmakers
- Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012
- Pharmaceutical Distribution
- Pharmaceutical Retail Sector
- Company Profile
- Berlin Pharmaceutical Industry
- Biolab
- GlaxoSmithKline
- Government Pharmaceutical Organisation
- Merck & Co
- Novartis
- Pfizer
- Sanofi
- Demographic Forecast
- Table: Population Headline Indicators (Thailand 1990-2025)
- Table: Key Population Ratios (Thailand 1990-2025)
- Table: Urban/Rural Population & Life Expectancy (Thailand 1990-2025)
- Table: Population By Age Group (Thailand 1990-2025)
- Table: Population By Age Group % (Thailand 1990-2025)
- Glossary
- Methodology
- Pharmaceutical Expenditure Forecast Model
- Healthcare Expenditure Forecast Model
- Notes On Methodology
- Risk/Reward Index Methodology
- Index Overview
- Table: Pharmaceutical Risk/Reward Index Indicators
- Indicator Weightings
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook